We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $182M
1-Year Est. Return 26.44%
This Fund
S&P 500
This Quarter Est. Return
-5.13%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.91%
AUM
$112M
AUM Growth
-$17.1M
Cap. Flow
-$10.1M
Cap. Flow %
-9.01%
Top 10 Hldgs %
47.54%
Holding
69
New
1
Increased
Reduced
30
Closed
7

Top Buys

Rank Stock Value
1
ACI icon
Albertsons Companies
ACI
+$1.27M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.8M
2
DHR icon
Danaher
DHR
+$2M
3
ADI icon
Analog Devices
ADI
+$1.53M
4
AGR
Avangrid, Inc.
AGR
+$1.18M
5
SSD icon
Simpson Manufacturing
SSD
+$1.05M

Sector Composition

Rank Sector Weight
1 Healthcare 30.98%
2 Technology 12.13%
3 Communication Services 12%
4 Industrials 11.02%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
51
Walt Disney
DIS
$167B
$336K 0.3%
3,565
INTC icon
52
Intel
INTC
$479B
$319K 0.28%
12,369
T icon
53
AT&T
T
$157B
$318K 0.28%
20,759
WBA
54
DELISTED
Walgreens Boots Alliance
WBA
$296K 0.26%
9,441
RGNX icon
55
Regenxbio
RGNX
$649M
$253K 0.22%
9,584
-125
-1% -$3.71K
GE icon
56
GE Aerospace
GE
$371B
$249K 0.22%
6,459
VZ icon
57
Verizon
VZ
$191B
$249K 0.22%
6,559
-1
-0% -$45
RVTY icon
58
Revvity
RVTY
$12.7B
$242K 0.22%
2,013
SJM icon
59
J.M. Smucker
SJM
$12.9B
$218K 0.19%
1,587
FRBK
60
DELISTED
Republic First Bancorp Inc
FRBK
$48K 0.04%
17,000
IMV
61
DELISTED
IMV Inc. Common Shares
IMV
$23K 0.02%
4,347
CBIO
62
Crescent Biopharma
CBIO
$548M
$8K 0.01%
140
ADI icon
63
Analog Devices
ADI
$179B
-10,445
Closed -$1.53M
AMD icon
64
Advanced Micro Devices
AMD
$819B
-2,885
Closed -$221K
G icon
65
Genpact
G
$5.92B
-89,651
Closed -$3.8M
IBM icon
66
IBM
IBM
$210B
-1,600
Closed -$226K
JPM icon
67
JPMorgan Chase
JPM
$932B
-1,798
Closed -$202K
SSD icon
68
Simpson Manufacturing
SSD
$7.65B
-10,435
Closed -$1.05M
WMS icon
69
Advanced Drainage Systems
WMS
$10.6B
-6,460
Closed -$582K

Similar funds

Prentiss Smith & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Prentiss Smith & Co held 69 positions worth $112M, down 13% from $130M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Prentiss Smith & Co withdrew a net $10.1M in Q3 2022, closing 7 positions and reducing 30 holdings. Its most notable exit was Genpact, an estimated $3.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Prentiss Smith & Co opened a new position in Albertsons Companies worth $1.16M.

  • Prentiss Smith & Co's largest Q3 2022 buy was Albertsons Companies: 46,593 shares worth $1.16M.
  • Prentiss Smith & Co's biggest Q3 2022 reduction was Danaher, cutting an estimated $2M.
  • Prentiss Smith & Co fully exited Genpact in Q3 2022, selling an estimated $3.8M.
  • Prentiss Smith & Co's ten largest holdings make up 48% of its $112M portfolio in Q3 2022.
  • Prentiss Smith & Co opened 1 new position and closed 7 in Q3 2022.
  • Prentiss Smith & Co's portfolio value fell 13% quarter-over-quarter to $112M.

Based on Prentiss Smith & Co's 13F filing for Q3 2022, filed 21 Oct 2022.